Journal of Virology,
Journal Year:
2017,
Volume and Issue:
91(23)
Published: Sept. 21, 2017
ABSTRACT
HIV-1
infection
of
noncycling
cells,
such
as
dendritic
cells
(DCs),
is
impaired
due
to
limited
availability
deoxynucleoside
triphosphates
(dNTPs),
which
are
needed
for
reverse
transcription.
The
levels
dNTPs
tightly
regulated
during
the
cell
cycle
and
depend
on
balance
between
dNTP
biosynthesis
degradation.
SAMHD1
potently
blocks
replication
in
DCs,
although
underlying
mechanism
still
unclear.
has
been
reported
be
able
degrade
viral
nucleic
acids,
may
both
hamper
relative
contribution
these
activities
differ
cycling
cells.
Here,
we
show
that
inhibition
monocyte-derived
DCs
(MDDCs)
associated
with
an
increased
expression
p21cip1/waf,
a
regulator
involved
differentiation
maturation
DCs.
Induction
p21
MDDCs
decreases
pool
increases
antiviral
active
isoform
SAMHD1.
Although
processes
complementary
inhibiting
replication,
activity
our
primary
model
appears
be,
at
least
partially,
independent
its
dNTPase
activity.
reduction
rather
mostly
p21-mediated
suppression
several
enzymes
synthesis
(i.e.,
RNR2,
TYMS,
TK-1).
These
results
important
better
understand
interplay
inform
design
new
therapeutic
approaches
decrease
dissemination
improve
immune
responses
against
HIV-1.
IMPORTANCE
play
key
role
induction
HIV.
However,
HIV
evolved
ways
exploit
facilitating
evasion
virus
dissemination.
We
have
found
p21,
cyclin-dependent
kinase
inhibitor
regulation
monocyte
maturation,
potentially
can
contribute
through
multiple
mechanisms.
decreased
size
intracellular
pool.
In
parallel,
prevented
phosphorylation
promoted
dNTPase-independent
Thus,
resulted
conditions
allowed
effective
Overall,
myeloid
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 17, 2025
SAMHD1
is
a
dNTPase
that
impedes
replication
of
HIV-1
in
myeloid
cells
and
resting
T
lymphocytes.
Here
we
elucidate
the
substrate
activation
mechanism
SAMHD1,
which
involves
dNTP
binding
at
allosteric
sites
transient
tetramerization.
Our
findings
reveal
tetramerization
alone
insufficient
to
promote
hydrolysis;
instead,
requires
an
inactive
tetrameric
intermediate
with
partially
occupied
sites.
The
equilibrium
between
active
states
regulates
activity,
driven
by
dissociation
additional
ligands
preassembled
tetramer.
Furthermore,
catalytic
efficiency,
but
not
specificity,
modulated
identity
dNTPs
occupying
We
show
how
this
regulation
shapes
deoxynucleotide
homeostasis
balancing
production
SAMHD1-catalyzed
depletion.
Notably,
exhibits
distinct
functionality,
term
facilitated
depletion,
whereby
increased
biosynthesis
certain
enhances
depletion
others.
regulatory
relationship
different
sheds
light
on
emerging
role
biology
implications
for
HIV/AIDS,
innate
antiviral
immunity,
cell
disorders,
telomere
maintenance
therapeutic
efficacy
nucleoside
analogs.
Viruses,
Journal Year:
2020,
Volume and Issue:
12(4), P. 382 - 382
Published: March 31, 2020
Deoxynucleoside
triphosphate
(dNTP)
molecules
are
essential
for
the
replication
and
maintenance
of
genomic
information
in
both
cells
a
variety
viral
pathogens.
While
process
dNTP
biosynthesis
by
cellular
enzymes,
such
as
ribonucleotide
reductase
(RNR)
thymidine
kinase
(TK),
has
been
extensively
investigated,
negative
regulatory
mechanism
pools
was
recently
found
to
involve
sterile
alpha
motif
(SAM)
domain
histidine-aspartate
(HD)
domain-containing
protein
1,
SAMHD1.
When
active,
triphosphohydrolase
activity
SAMHD1
degrades
dNTPs
into
their
2'-deoxynucleoside
(dN)
subparts,
steadily
depleting
intercellular
pools.
The
differential
expression
levels
activation
states
various
cell
types
contributes
unique
that
either
aid
(i.e.,
dividing
T
cells)
or
restrict
nondividing
macrophages)
consumes
dNTPs.
Genetic
mutations
induce
rare
inflammatory
encephalopathy
called
Aicardi-Goutières
syndrome
(AGS),
which
phenotypically
resembles
infection.
Recent
publications
have
identified
diverse
roles
double-stranded
break
repair,
genome
stability,
stress
response
through
interferon
signaling.
Finally,
series
were
also
reported
cancer
while
why
is
mutated
these
remains
investigated.
Here,
we
reviewed
studies
begun
illuminating
highly
virology,
immunology,
biology.
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: Oct. 23, 2019
Human
Immunodeficiency
Virus
(HIV)
infects
cells
from
the
immune
system
and
has
thus
developed
tools
to
circumvent
host
immunity
use
it
in
its
advance.
Dendritic
(DCs)
are
first
encounter
HIV,
being
main
antigen
(Ag)
presenting
cells,
they
link
innate
adaptive
responses.
While
DCs
work
promote
an
efficient
response
halt
infection,
HIV-1
ways
take
advantage
of
their
role
uses
gain
faster
more
access
CD4+
T
cells.
Due
ability
activate
a
specific
response,
promising
candidates
achieve
functional
cure
but
knowing
molecular
partakers
that
determine
relationship
between
virus
cell
is
key
for
rational
successful
design
DC-based
therapy.
In
this
review,
we
summarize
current
state
knowledge
on
how
both
DC
subsets
(myeloid
plasmacytoid
DCs)
act
presence
HIV-1,
focus
different
pathways
can
after
binding
DC.
First,
explore
consequences
recognition
by
each
receptor
DCs,
including
CD4
DC-SIGN.
Second,
look
at
cellular
mechanisms
prevent
productive
infection
weapons
turn
defense
into
Trojan
horse
hides
all
way
cell.
Finally,
discuss
possible
outcomes
DC-T
contact.
Scientific Reports,
Journal Year:
2016,
Volume and Issue:
6(1)
Published: Aug. 11, 2016
Abstract
SAMHD1,
a
dNTP
triphosphohydrolase,
contributes
to
interferon
signaling
and
restriction
of
retroviral
replication.
SAMHD1-mediated
is
thought
result
from
the
depletion
cellular
pools,
but
it
remains
controversial
whether
dNTPase
activity
SAMHD1
sufficient
for
restriction.
The
ability
regulated
in
cells
by
phosphorylation
on
T592.
Phosphomimetic
mutations
T592
are
not
competent,
appear
intact
their
deplete
dNTPs.
Here
we
use
analytical
ultracentrifugation,
fluorescence
polarization
NMR-based
enzymatic
assays
investigate
impact
phosphomimetic
tetramerization
vitro
.
We
find
that
affect
kinetics
tetramer
assembly
disassembly,
effects
equilibrium
insignificant.
In
contrast,
Y146S/Y154S
dimerization-defective
mutant
displays
severe
defect
,
indistinguishable
WT
its
pools
restrict
HIV
Our
data
suggest
effect
likely
explain
hypothesize
subject
additional
regulatory
mechanisms
have
yet
been
recapitulated
EMBO Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
12(3)
Published: Jan. 17, 2020
The
deoxycytidine
analogue
cytarabine
(ara-C)
remains
the
backbone
treatment
of
acute
myeloid
leukaemia
(AML)
as
well
other
haematological
and
lymphoid
malignancies,
but
must
be
combined
with
chemotherapeutics
to
achieve
cure.
Yet,
underlying
mechanism
dictating
synergistic
efficacy
combination
chemotherapy
largely
unknown.
dNTPase
SAMHD1,
which
regulates
dNTP
homoeostasis
antagonistically
ribonucleotide
reductase
(RNR),
limits
ara-C
by
hydrolysing
active
triphosphate
metabolite
ara-CTP.
Here,
we
report
that
clinically
used
inhibitors
RNR,
such
gemcitabine
hydroxyurea,
overcome
SAMHD1-mediated
barrier
in
primary
blasts
mouse
models
AML,
displaying
SAMHD1-dependent
synergy
ara-C.
We
present
evidence
this
is
mediated
pool
imbalances
leading
allosteric
reduction
SAMHD1
ara-CTPase
activity.
Thus,
constitutes
a
novel
biomarker
for
therapies
RNR
immediate
consequences
clinical
practice
improve
AML.